Chongqing Xier'an Pharmaceutical Co., Ltd. originated in the 37th year of the Kangxi reign (1698 AD). At that time, the Tai Scholar Wu Hongxian created the "Wu Shu Fragrance Room" at the entrance of Taipingmen Fish Market on the Yuzhou Peninsula in ancient Chongqing. Business has been booming for hundreds of years and Debu is the whole country. The traditional production techniques of Wu Shufang plaster are an intangible cultural heritage in Chongqing, and Xier'an Pharmaceutical is a demonstration production base for intangible cultural heritage in Chongqing.

Xieran Pharmaceutical has always adhered to the corporate philosophy of "democracy and medicine to benefit the people", adhered to the corporate goal of "building a 10 billion pharmaceutical company, and shaping the top ten traditional Chinese medicine brands Wu Shufang". Now it has developed into a comprehensive R&D, A comprehensive pharmaceutical company integrating production and sales. The company's total assets are nearly 2 billion yuan. The company has been rated as a national key high-tech enterprise, a leading enterprise in the national biological industry base, and a national key leading enterprise in agricultural industrialization.

Xier'an Production Base is located in Hechuan Industrial Park, Chongqing, covering an area of ​​more than 500 mu. In recent years, the company has vigorously promoted the construction of intelligent manufacturing, realizing intelligent production integration, data integration, equipment intelligence, and production management intelligence. 16 dosage forms and one drug substance passed the GMP compliance test. The company has rich product resources and has 204 production approval documents.

The company vigorously implements the marketing strategy of "building the foundation, increasing thickness; wide coverage, and deepening cultivation". The sales network covers all other provinces, municipalities and autonomous regions in China except Hong Kong, Macao, Taiwan and Tibet, as well as Southeast Asia, Europe, America and other parts. Overseas markets have formed a sales pattern of in-depth cultivation from provincial capital city comprehensive hospitals to district and county health centers, individual clinics, and retail pharmacies, and are committed to creating a number of product lines with competitive advantages such as orthopedics, pediatrics, and dermatology. The company's 83 varieties are included in the "National Basic Medical Insurance Drug Catalog"; 29 varieties are included in the "National Basic Medical Catalog"; and 3 national traditional Chinese medicine protected varieties. The company's key varieties such as Xiaole Huanglong Granules, Jinchan Anti-Itch Capsules, Musk Wind-Chasing Pain Relieving Pain, Qili Tablets, etc. are all exclusive or patented products. They have won the National, Provincial and Municipal Science and Technology Progress Award, Chongqing Major New Products, Chongqing City's high-tech products and other honors.

The company adheres to the scientific research strategy of "scientific and technological service to mankind, innovation promotes development", uses science and technology as a means, adheres to the scientific research policy of "combining imitation and creation, paying equal attention to drug and big health products", screening, developing and reserveing ​​a batch of products. R&D pattern. The company's major shareholders invested in the establishment of two R&D institutions - Chongqing Cisco Pharmaceutical Research and Development Co., Ltd. and Chongqing Kerun Biopharmaceutical Research and Development Co., Ltd., which are the national enterprise technology center and the national major science and technology special project "major new drug creation" yeast recombinant protein drug trial Amplification technology platform, Chongqing Engineering Research Center for Recombinant Protein Drugs, Chongqing Postdoctoral Research Workstation, Chongqing Traditional Chinese Medicine Preparation Process Engineering Technology Research Center, Chongqing Traditional Chinese Medicine Rubber Paste Chongqing Key Laboratory of Industry and Information Technology.

Xier'an actively explores the mechanism of joint school-running, joint construction of schools and enterprises and integration of industry and education, jointly builds the "Bio-medical Collaborative Innovation Center", promotes scientific and technological exchanges and cooperation between universities, research institutes and enterprises, complements each other's strengths, and strengthens the transformation of innovative achievements. With first-class domestic and foreign scientific research institutes, universities and medical experts as technical support, Xier'an has organized a huge external brain network to carry out extensive industry-university research. The cooperative units include: Chinese Academy of Traditional Chinese Medicine, Chinese Academy of Military Medical Sciences, Beijing University of Traditional Chinese Medicine, Georgia Institute of Technology, West China Medical University, Chengdu University of Traditional Chinese Medicine, Chongqing Medical University, Third Military Medical University, and Chongqing Institute of Traditional Chinese Medicine.